Atlas Trials

Third Dose Vaccination With AstraZeneca or Pfizer COVID-19 Vaccine Among Adults Received Sinovac COVID-19 Vaccine

Clinical trial NCT05049226 · COMPLETED

Trial details

NCT number
NCT05049226
Sponsor
Mahidol University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
COVID-19 InfectionCOVID-19 VACCINE
Start date
2021-09-24
Primary completion
2022-02-22
Enrollment
1250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.